Tailored neoadjuvant epirubicin and cyclophosphamide and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer

Authors :: Linda West
Karen White
Wei Duan
Inger Olesen
Violet Rudo Mukaro
Anne Woollett
Sally Baron-Hay
Theresa M. Hayes
Mustafa Khasraw
Kimberley Prince
Gregory Mitchell
David M. Ashley
Sujata Patil
Susan Bowles
Shu Fen Wong
Sandra L Harvey
Conrad Brandt
Robert Spokes
Source :: Journal of Clinical Oncology. 32:TPS1135-TPS1135
Publication Year :: 2014
Publisher :: American Society of Clinical Oncology (ASCO), 2014.
Abstract: TPS1135 Background: Neoadjuvant chemotherapy for breast cancer allows response to be assessed depending on subtype, and to judge impact of response to therapy on progression-free survival (PFS). Me...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Chemotherapy
Response to therapy
Cyclophosphamide
business.industry
medicine.medical_treatment
Albumin
Newly diagnosed
medicine.disease
Breast cancer
Internal medicine
Medicine
business
Epirubicin
medicine.drug
Nab-paclitaxel

Tools